Evaluation of Self-adhesive Hybrid Resin Composite Compared to a Traditional Composite Resin in Restorations of NCCLs

November 22, 2024 updated by: Dentsply Sirona Implants and Consumables

3-year Evaluation of the Clinical Performances of a Self-adhesive Hybrid Resin Composite Compared to a Traditional Composite Resin Used for Direct Restorations of Non-carious Cervical Lesions (NCCLs): A Split-mouth Randomized Clinical Trial

This is a split-mouth randomized clinical investigation conducted to evaluate clinical performances of a self-adhesive hybrid resin composite (investigational medical device Surefil) compared to a traditional composite resin, when used for direct restorations of non-carious lesions (NCCLs). The study consists of a 3-year long follow-up period.

Study Overview

Status

Terminated

Conditions

Detailed Description

The aim of this study is to demonstrate non-inferiority in terms of clinical performance and patient discomfort after direct restorative treatment of class V NCCL with Surefil one restorative material (Dentsply Sirona) in combination with a traditional paste composite "Venus Pearl" employed in combination with iBond universal adhesive (Kulzer Dental) during an observational period of 3 years.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bologna, Italy, 40125
        • Clinica Odontoiatrica (DIBINEM)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aging from 18 to 70
  • 40-60% women, 40-60% men
  • Patients who present at least 2 cervical lesions on canines and / or upper premolars on vital teeth
  • Patients who are not allergic or sensitive to the ingredients contained in the products
  • The test patient consents to the restorative treatment in line with the study´s criteria (informed consent)
  • Sufficiently understanding of the language

Exclusion Criteria:

  • Extremely low level of oral hygiene
  • Teeth with previous restorations
  • Not possible adequate isolation of the operating area
  • Patients with serious systemic diseases
  • Devitalized teeth or with pulpitis in progress
  • Periodontal problems on the elements to be restored

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Restoration with Surefil one hybrid composite

In a split-mouth design, subjects were randomly assigned to restoration with Surefil one hybrid composite in either the left or the right upper quadrant.

Restoration performed with Surefil one hybrid composite applied according to manufacturer's instruction and cured for 20 seconds with a LED lamp (Smartlamp Pro).

Restorative material (Dentsply Sirona). Used for direct restoration of class V NCCL.
Active Comparator: Restoration with Venus Pearl composite

In a split-mouth design, subjects were randomly assigned to restoration with Venus Pearl composite in either the left or the right upper quadrant.

After the application of the adhesive system (iBond universal), the Venus Pearl composite will be layered on the cavity and cured for 20 seconds with a LED lamp Smartlamp Pro).

Restorative material. Traditional paste composite employed in combination with iBond universal adhesive.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Restorative Quality
Time Frame: At 36 months follow-up.
The restorations will be evaluated using the World Dental Federation (FDI) criteria.
At 36 months follow-up.
Assessment of Restorative Quality
Time Frame: At 36 months follow-up
The restorations will be evaluated using the United States Public Health Service (USPHS) criteria.
At 36 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Restorative Quality
Time Frame: At 6, 12 and 24 months follow-up
The restorations will be evaluated using the FDI criteria.
At 6, 12 and 24 months follow-up
Assessment of Restorative Quality
Time Frame: At 6, 12 and 24 months follow-up
The restorations will be evaluated using the USPHS criteria.
At 6, 12 and 24 months follow-up
Assessment of Aesthetics
Time Frame: At 6, 12, 24 and 36 months follow-up
The aesthetic integration of the restoration will be evaluated by two experienced and blinded operators following the aesthetic criteria of the FDI.
At 6, 12, 24 and 36 months follow-up
Level of Pain
Time Frame: At 6, 12, 24 and 36 months follow-up
Sensitivity index: thermal yes/no, if yes then Visual Analogue Scale (VAS) index for level of pain. Air yes/no, if yes then VAS index for level of pain.
At 6, 12, 24 and 36 months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time Needed to Perform the Restoration
Time Frame: Day 0
The time needed to perform the restorations will be compared between the groups.
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lorenzo Breschi, Prof, Clinica Odontoiatrica (DIBINEM)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 21, 2022

Primary Completion (Actual)

January 22, 2024

Study Completion (Actual)

January 22, 2024

Study Registration Dates

First Submitted

February 7, 2023

First Submitted That Met QC Criteria

February 20, 2023

First Posted (Actual)

March 2, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

November 22, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 14.1535

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Restoration

Clinical Trials on Surefil one

Subscribe